Article ; Online: Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis.
2020 Volume 120, Issue 11, Page(s) 1524–1535
Abstract: Background: The aim of this meta-analysis is to assess the prevalence of coagulation dysfunction in Chinese COVID-19 patients and to determine the association of coagulopathy with the severity and prognosis of COVID-19.: Methods: A meta-analysis of ...
Abstract | Background: The aim of this meta-analysis is to assess the prevalence of coagulation dysfunction in Chinese COVID-19 patients and to determine the association of coagulopathy with the severity and prognosis of COVID-19. Methods: A meta-analysis of the prevalence of different abnormal coagulation indicators in COVID-19 patients in China was performed. The difference of coagulation indicators and the incidence of DIC were compared between severe cases and nonsevere cases as well as nonsurvivors and survivors, respectively. Results: A total of 22 Chinese studies involving 4,889 confirmed COVID-19 inpatients were included. The average D-dimer value of COVID-19 patients is 0.67 µg/mL (95% confidence interval [CI]: 0.56-0.78), and 29.3% (95% CI: 20.1-38.5%) of patients showed elevated D-dimer values. Severe patients had significantly higher D-dimer levels and prolonged prothrombin time (PT) compared with nonsevere patients. Nonsurvivors had significantly higher D-dimer levels, prolonged PT, and decreased platelet count compared with survivors. In total, 6.2% (95% CI: 2.6-9.9%) COVID-19 patients were complicated by disseminated intravascular coagulation (DIC), in which the log risk ratio in nonsurvivors was 3.267 (95% CI: 2.191-4.342, Conclusion: The prevalence of coagulopathy in Chinese COVID-19 inpatients is high, and both the abnormal coagulation indicators and DIC are closely associated with the severity and poor prognosis of these COVID-19 patients. Therefore, attention should be paid to coagulation dysfunction in COVID-19 patients. Closely monitoring of coagulation indicators and application of appropriate anticoagulation may improve the prognosis of COVID-19 inpatients in China. |
---|---|
MeSH term(s) | Adult ; Aged ; Aged, 80 and over ; Anticoagulants/therapeutic use ; Blood Coagulation/drug effects ; Blood Coagulation Disorders/blood ; Blood Coagulation Disorders/drug therapy ; Blood Coagulation Disorders/epidemiology ; Blood Coagulation Disorders/mortality ; COVID-19 ; China/epidemiology ; Coronavirus Infections/blood ; Coronavirus Infections/epidemiology ; Coronavirus Infections/mortality ; Coronavirus Infections/therapy ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/mortality ; Pneumonia, Viral/therapy ; Prevalence ; Prognosis ; Risk Assessment ; Risk Factors ; Severity of Illness Index |
Chemical Substances | Anticoagulants |
Keywords | covid19 |
Language | English |
Publishing date | 2020-07-17 |
Publishing country | Germany |
Document type | Journal Article ; Meta-Analysis ; Systematic Review |
ZDB-ID | 518294-3 |
ISSN | 2567-689X ; 0340-6245 |
ISSN (online) | 2567-689X |
ISSN | 0340-6245 |
DOI | 10.1055/s-0040-1714369 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uh III Zs.192: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 433: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.